XTL Biopharmaceuticals Ltd SEC filings XTLB

XTL Biopharmaceuticals Ltd has 546 filings in SEC EDGAR's recent list, going back to Nov 17, 2004. Its latest annual report, Form 20-F, was filed on Jun 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 14, 2026.

Form Description Filed Period
3 Initial insider ownership Mar 23, 2026 Mar 18, 2026
3 Initial insider ownership Mar 23, 2026 Mar 18, 2026
SC 13G/A Amended ownership over 5% (passive) Jan 5, 2018 —
SC 13G Ownership over 5% (passive) Feb 27, 2017 —
SC 13G/A Amended ownership over 5% (passive) Jan 6, 2017 —
SC 13G/A Amended ownership over 5% (passive) Jan 12, 2016 —
SC 13G Ownership over 5% (passive) Apr 2, 2015 —
SC 13G/A Amended ownership over 5% (passive) Feb 27, 2009 —
SC 13D/A Amended ownership over 5% (active) Dec 3, 2008 —
4 Insider transaction Dec 3, 2008 Nov 18, 2008
4 Insider transaction Nov 4, 2008 Oct 10, 2008
4 Insider transaction Nov 4, 2008 Dec 30, 2007
3 Initial insider ownership Nov 4, 2008 Oct 10, 2008
3 Initial insider ownership Nov 4, 2008 Oct 10, 2008
3 Initial insider ownership Nov 4, 2008 Aug 1, 2005
3 Initial insider ownership Nov 4, 2008 Oct 10, 2008
3 Initial insider ownership Sep 4, 2008 Aug 27, 2008
3 Initial insider ownership Aug 26, 2008 Aug 22, 2008
SC 13D/A Amended ownership over 5% (active) Jul 18, 2008 —
SC 13D Ownership over 5% (active) Jul 17, 2008 —
4 Insider transaction Jun 19, 2008 Jun 10, 2008
4 Insider transaction Jun 11, 2008 Jun 5, 2008
4 Insider transaction Jun 6, 2008 Jun 3, 2008
4 Insider transaction May 6, 2008 May 1, 2008
4 Insider transaction May 2, 2008 Apr 29, 2008
4 Insider transaction Apr 16, 2008 Apr 10, 2008
4 Insider transaction Apr 4, 2008 Apr 1, 2008
4 Insider transaction Apr 2, 2008 Mar 28, 2008
4 Insider transaction Mar 20, 2008 Mar 12, 2008
4 Insider transaction Mar 19, 2008 Mar 10, 2008
4 Insider transaction Mar 19, 2008 Mar 6, 2008
4 Insider transaction Mar 10, 2008 Mar 4, 2008
4 Insider transaction Feb 29, 2008 Feb 27, 2008
SC 13G/A Amended ownership over 5% (passive) Feb 29, 2008 —
4 Insider transaction Feb 28, 2008 Feb 22, 2008
4 Insider transaction Feb 28, 2008 Feb 26, 2008
4 Insider transaction Feb 22, 2008 Feb 20, 2008
4 Insider transaction Feb 19, 2008 Feb 13, 2008
4 Insider transaction Feb 8, 2008 Feb 6, 2008
4 Insider transaction Feb 6, 2008 Feb 4, 2008
4 Insider transaction Feb 5, 2008 Jan 31, 2008
4 Insider transaction Feb 1, 2008 Jan 30, 2008
4 Insider transaction Jan 30, 2008 Jan 28, 2008
4 Insider transaction Jan 29, 2008 Jan 25, 2008
4 Insider transaction Jan 28, 2008 Jan 23, 2008
4 Insider transaction Jan 25, 2008 Jan 15, 2008
4 Insider transaction Jan 18, 2008 Jan 15, 2008
4 Insider transaction Jan 15, 2008 Jan 11, 2008
SC 13G Ownership over 5% (passive) Jan 14, 2008 —
4 Insider transaction Jan 11, 2008 Jan 7, 2008
4 Insider transaction Jan 8, 2008 Jan 3, 2008
4 Insider transaction Jan 4, 2008 Jan 2, 2008
4 Insider transaction Jan 2, 2008 Dec 28, 2007
4 Insider transaction Dec 31, 2007 Dec 27, 2007
3/A Filing Dec 31, 2007 Nov 29, 2007
SC 13G/A Amended ownership over 5% (passive) Dec 7, 2007 —
3 Initial insider ownership Dec 7, 2007 Nov 29, 2007
SC 13G Ownership over 5% (passive) Sep 18, 2007 —
3 Initial insider ownership Aug 22, 2007 Aug 21, 2007
4 Insider transaction Aug 21, 2007 Aug 21, 2007
4 Insider transaction Aug 28, 2006 Aug 25, 2006
3 Initial insider ownership Aug 17, 2006 Aug 17, 2006

Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
XTLB (Nasdaq)
Incorporated in
Israel
Headquarters
New York, NY
SEC filer status
Non-accelerated filer
SEC CIK
1023549

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.